Home India CHEMICALS AND FERTILIZERS Parliament Question: Medicines at Jan Aushadhi Kendras...
Date: 2026-02-13 Category: Not Applicable State: Union Government Country: India

Parliament Question: Medicines at Jan Aushadhi Kendras

Issued by CHEMICALS AND FERTILIZERS · Not Applicable

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

**Executive Summary** This document is the answer from the Minister of State in the Ministry of Chemicals and Fertilizers to an unstarred question in Lok Sabha regarding Jan Aushadhi Kendras. The answer details the number of operational Kendras as of December 31, 2025, the price difference between generic and branded medicines, and the government's efforts to promote the prescription of generic medicines. The Medical Council of India issued a circular on April 21, 2017, directing registered medical practitioners to comply with the requirement to prescribe drugs with generic names. **Key Points / Main Content** * **Jan Aushadhi Kendras (JAKs):** * As of December 31, 2025, a total of 17,990 JAKs are operational across the country under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana. Annexure I provides a state-wise/Union Territory-wise breakdown. * Medicines at JAKs are available at rates approximately 50% to 80% cheaper than equivalent branded alternatives. * **Prescription of Generic Medicines:** * Paragraph 1.5 of the Code of Medical Ethics in the Indian Medical Council Regulations, 2002 mandates that physicians prescribe drugs using generic names legibly, preferably in capital letters, ensuring rational prescription and use. * The Medical Council of India issued a circular on April 21, 2017 (Annexure II), directing all registered medical practitioners to comply with this requirement. * The Pharmaceuticals & Medical Devices Bureau of India (PMBI) undertakes initiatives to inform doctors about the benefits of generic medicines through campaigns. * Media campaigns are conducted to encourage citizens to request prescriptions for generic medicines. **Impact Analysis** **Indian Medical Practitioners** * **Impact:** Must adhere to the Code of Medical Ethics and the Medical Council of India's directives regarding the prescription of generic medicines. Non-compliance can lead to disciplinary action. * **Action Required:** Prescribe drugs using generic names legibly, preferably in capital letters. **Citizens** * **Impact:** Increased access to affordable medicines through Jan Aushadhi Kendras and greater likelihood of receiving prescriptions for generic drugs. * **Action Required:** Request prescriptions for generic medicines during consultations with their physicians. **State Medical Councils/Medical Council of India (SMC/MCI)** * **Impact:** Responsible for ensuring compliance with the ethical guidelines and regulations regarding generic drug prescriptions. * **Action Required:** Take appropriate disciplinary action against doctors found violating the regulations. **Pharmaceuticals & Medical Devices Bureau of India (PMBI)** * **Impact:** Implementing agency for the Jan Aushadhi scheme. * **Action Required:** To continue to apprise doctors about the scheme and the benefits of generic medicines through briefing and media campaigns to raise awareness among citizens.

Key Entities Referenced

Pradhan Mantri Bhartiya Janaushadhi Pariyojana: A scheme to provide quality medicines at affordable prices through Jan Aushadhi Kendras. Jan Aushadhi Kendras (JAKs): Dedicated outlets opened across the country to provide medicines at rates that are about 50% to 80% cheaper than those of equivalent branded alternatives, under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana. Ministry of Chemicals and Fertilizers: The primary ministry responsible for addressing the question regarding medicines at Jan Aushadhi Kendras. Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002: Regulations mandating physicians to prescribe drugs with generic names. Pharmaceuticals & Medical Devices Bureau of India (PMBI): The scheme implementing agency for the Janaushadhi program.
Official Source Record View Original Source →
See Full Document Text
GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS LOK SABHA UNSTARRED QUESTION No. 2319 TO BE ANSWERED ON 13th FEBRUARY, 2026 Medicines at Jan Aushadhi Kendras †2319. Shri Sanatan Pandey: Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state: (a) the number of Jan Aushadhi Kendras operational in the country, State-wise; (b) the details of price difference between medicines sold through Jan Aushadhi Kendras and their branded alternatives; (c) whether many doctors do not prescribe medicines by their generic names; and (d) if so, the details thereof along with the steps taken/proposed to be taken by the Government in this regard? ANSWER THE MINISTER OF STATE IN THE MINISTRY OF CHEMICALS AND FERTILIZERS (SMT. ANUPRIYA PATEL) (a) and (b): Under Pradhan Mantri Bhartiya Janaushadhi Pariyojana, a total of 17,990 JAKs have been opened across the country as on 31.12.2025. The State-wise /Union Territory-wise number of JAKs opened across the country is at Annexure I. Under the Scheme, dedicated outlets known as Jan Aushadhi Kendras (JAKs) are opened across the country to provide medicines at rates that are about 50% to 80% cheaper than those of equivalent branded alternatives. (c) and (d): Paragraph 1.5 of the Code of Medical Ethics in the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002 requires that every physician should prescribe drugs with generic names legibly and preferably in capital letters and that the physician shall ensure that there is a rational prescription and use of drugs. Moreover, the Medical Council of India has issued circular date 21.04.2017 (Annexure II) directing all registered medical practitioners to comply with the said requirement. In addition to above, the scheme implementing agency i.e. Pharmaceuticals & Medical Devices Bureau of India (PMBI) takes steps to apprise doctors about the scheme and the benefits of generic medicines. The doctors are briefed about the quality and affordability of Janaushadhi medicines through these campaigns. Further, extensive media campaigns are carried out to create awareness among the citizens so that they can request for prescriptions of generic medicines during consultations with their physicians/doctors.Annexure I Annexure referred to in reply to parts (a) and (b) of the LOK SABHA UNSTARRED Q. No. 2319 for answer on 13.02.2026, raised by Shri Sanatan Pandey, regarding “Medicines at Jan Aushadhi Kendras” The State-wise /Union Territory-wise number of JAKs opened as on 31.12.2025 S. No. State / Union territory Number of JAKs opened 1 Andaman and Nicobar Islands 6 2 Andhra Pradesh 272 3 Arunachal Pradesh 35 4 Assam 176 5 Bihar 1058 6 Chandigarh 19 7 Chhattisgarh 345 8 Delhi 589 9 Goa 18 10 Gujarat 848 11 Haryana 474 12 Himachal Pradesh 74 13 Jammu and Kashmir 351 14 Jharkhand 166 15 Karnataka 1585 16 Kerala 1714 17 Ladakh 3 18 Lakshadweep 1 19 Madhya Pradesh 614 20 Maharashtra 713 21 Manipur 68 22 Meghalaya 25 23 Mizoram 16 24 Nagaland 22 25 Odisha 803 26 Puducherry 33 27 Punjab 532 28 Rajasthan 632 29 Sikkim 15 30 Tamil Nadu 1515 31 Telangana 212 32 The Dadra and Nagar Haveli and Daman and Diu 40 33 Tripura 33 34 Uttar Pradesh 3805 35 Uttarakhand 319 36 West Bengal 859 Total 17,990Annexure II Annexure referred to in reply to parts (c) and (d) of the LOK SABHA UNSTARRED Q. No. 2319 for answer on 13.02.2026, raised by Shri Sanatan Pandey, regarding “Medicines at Jan Aushadhi Kendras” Medical Council of India circular date 21.04.2017 *****

Continue your research